Updated:
GlassWall Syndicate
The GlassWall Syndicate is a collective of venture capitalists, foundations, trusts, non-profits, and individual investors. They focus on investments that...
GlassWall Syndicate
The GlassWall Syndicate is a collective of venture capitalists, foundations, trusts, non-profits, and individual investors. They focus on investments that benefit animals, people, and the planet. The syndicate has made 10 investments, including a Pre-Seed investment in Uncaged Innovations on June 02, 2023.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
North America
Country
United States
City
Overland Park
Corporate office
Overland Park, KS, United States
Sector focus
Frequently asked questions
Is GlassWall Syndicate a venture capital firm or a nonprofit foundation?
It operates as both—a 501(c)(3) nonprofit that makes venture-style investments in early-stage alternative protein companies. Returns from successful exits are recycled back into the mission rather than distributed to limited partners, which allows the firm to target impact without the conventional fund return timeline.
What investment stages does GlassWall Syndicate focus on?
The syndicate concentrates on pre-seed and seed rounds where scientific risk remains high and traditional venture capital has not yet committed. It occasionally participates in Series A rounds for companies emerging from initial technical milestones. The firm prioritizes capital efficiency at stages where a small check can meaningfully advance core research.
Which sectors does GlassWall Syndicate explicitly invest in?
The firm targets cellular agriculture, precision fermentation, and plant-based protein technologies. This includes startups developing cultivated meat scaffolds, animal-free dairy proteins via microbial fermentation, and bioreactor-based manufacturing processes. It does not invest in general food tech, restaurant concepts, or conventional agriculture improvement.
How does GlassWall Syndicate measure impact beyond financial returns?
The firm evaluates portfolio companies based on their potential to displace animals from the industrial food system, measuring metrics such as projected reduction in factory-farmed animals, greenhouse gas emissions avoided, and total capital catalyzed into the alternative protein sector. The nonprofit structure makes these impact metrics primary, with financial sustainability serving the mission.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: